Keywords: endo, shares, jump, 3rd-qtr, results, pharmaceuticals, saw
Endo's shares jump on 3rd-qtr results
Article | 25 October 2004
Endo Pharmaceuticals saw its share price leap 13.3% to $20.85 on October 14, as the firm reported better-than-expected earnings for the third quarter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
